Biotech Stock Review Adds Hancock Jaffe (HJLI) $1.05 to Watch List.

Adding to Watch List on Heels of 90 Day Results, From First Small 'In-Man' Trial to Treat Chronic Venous Insufficiency affecting the...

Emerald Organic Products, Inc. (EMOR) Announces Exclusive Licensing Agreement With PetVivo Holdings Inc. (PETV).

New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) ("Emerald" or the "Company") is pleased to announce...
Aphex BioCleanse

Aphex BioCleanse Systems. Our Favorite CoronaVirus Story.

Former Eastman Kodak Scientist and Engineers Develop Liquid Germ Killer Hy-IQ® to Revolutionize the way Deadly Bacteria and Virus are Eradicated
Lindsay Rosenwald, Biotech Stock Review

Newsworthy: Fortress Bio (FBIO) $1.73, Gets $20 Price Target!

Adding Fortress to Biotech Stock Review Watch List @ $1.73. Misunderstood by Wall Street which tends to 'over-analyze'...

SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations

Washington D.C., Aug. 20, 2019 — The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered...

Todos Medical (TOMDF) Issues Another CoronaVirus Headline, Gains 60%.

Companies With 'CoronaVirus' in Their Press Release Today: Waitr (WTRH) up 86% - Online Food Ordering for Quarantined...
aytu, innovus

AYTU (ATYU) ‘Team’ Letter on Innovus (INNV) Acquisition.

Aytu Team: I’m pleased to share with you some exciting, transformational news about Aytu BioScience that we announced publicly...
biotech stock review

Innovus (INNV) Gains 75% in Past Week.

After Rough Sledding Post Reverse Split, Client Innovus Receives Buyout Offer From Nasdaq Listed Ayto Biosciences (AYTU). Click...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...